These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28300604)

  • 1. Altered activation of peripheral CD8+ T cells in pediatric Crohn's disease.
    Orbán C; Szabó D; Bajnok A; Vásárhelyi B; Tulassay T; Arató A; Veres G; Toldi G
    Immunol Lett; 2017 May; 185():48-51. PubMed ID: 28300604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis.
    Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A
    Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered calcium influx of peripheral Th2 cells in pediatric Crohn's disease: infliximab may normalize activation patterns.
    Orbán C; Szabó D; Bajnok A; Vásárhelyi B; Tulassay T; Arató A; Veres G; Toldi G
    Oncotarget; 2016 Jul; 7(29):44966-44974. PubMed ID: 27329601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in the neonate.
    Toldi G; Treszl A; Pongor V; Gyarmati B; Tulassay T; Vásárhelyi B
    Int Immunol; 2010 Sep; 22(9):769-74. PubMed ID: 20601376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium influx kinetics, and the features of potassium channels of peripheral lymphocytes in primary Sjögren's syndrome.
    Legány N; Toldi G; Orbán C; Megyes N; Bajnok A; Balog A
    Immunobiology; 2016 Nov; 221(11):1266-72. PubMed ID: 27346388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte activation in type 1 diabetes mellitus: the increased significance of Kv1.3 potassium channels.
    Toldi G; Vásárhelyi B; Kaposi A; Mészáros G; Pánczél P; Hosszufalusi N; Tulassay T; Treszl A
    Immunol Lett; 2010 Sep; 133(1):35-41. PubMed ID: 20603149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in healthy pregnancy and preeclampsia.
    Toldi G; Stenczer B; Treszl A; Kollár S; Molvarec A; Tulassay T; Rigó J; Vásárhelyi B
    Am J Reprod Immunol; 2011 Feb; 65(2):154-63. PubMed ID: 20649894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets.
    Orbán C; Bajnok A; Vásárhelyi B; Tulassay T; Toldi G
    Cytometry A; 2014 Jul; 85(7):636-41. PubMed ID: 24827427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
    Hansen LK
    Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium Influx Kinetics and the Characteristics of Potassium Channels in Peripheral T Lymphocytes in Systemic Sclerosis.
    Toldi G; Legány N; Ocsovszki I; Balog A
    Pathobiology; 2020; 87(5):311-316. PubMed ID: 32911471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of aging on calcium influx and potassium channel characteristics of T lymphocytes.
    Kollár S; Berta L; Vásárhelyi ZE; Balog A; Vásárhelyi B; Rigó J; Toldi G
    Oncotarget; 2015 May; 6(15):13750-6. PubMed ID: 25948778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of Kv1.3 and IKCa1 channel inhibition on cytokine production and calcium influx of T lymphocytes in rheumatoid arthritis and ankylosing spondylitis.
    Toldi G; Munoz L; Herrmann M; Schett G; Balog A
    Immunol Res; 2016 Apr; 64(2):627-31. PubMed ID: 26280090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis by flow cytometry of calcium influx kinetics in peripheral lymphocytes of patients with rheumatoid arthritis.
    Bajnok A; Kaposi A; Kovács L; Vásárhelyi B; Balog A; Toldi G
    Cytometry A; 2013 Mar; 83(3):287-93. PubMed ID: 23335202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kv1.3 lymphocyte potassium channel inhibition as a potential novel therapeutic target in acute ischemic stroke.
    Folyovich A; Biro E; Orban C; Bajnok A; Vasarhelyi B; Toldi G
    CNS Neurol Disord Drug Targets; 2014; 13(5):801-6. PubMed ID: 25012622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Voltage-dependent potassium channel and calcium-activated potassium channel current changes of peripheral blood T-lymphocytes from hypertensive patients in Xinjiang Kazakh].
    Zhang QB; Zhang YM; Cheng LF; Yuan QY; Zhang GM; Liang P; Gou F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Dec; 41(12):1020-4. PubMed ID: 24524604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potassium channel changes of peripheral blood T-lymphocytes from Kazakh hypertensive patients in Northwest China and the inhibition effect towards potassium channels by telmisartan.
    Zhang Q; Gou F; Zhang Y; He Y; He J; Peng L; Cheng L; Yuan Q; Zhang G; Huang S
    Kardiol Pol; 2016; 74(5):476-488. PubMed ID: 26502942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
    Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the infliximab therapy of severe form of pediatric Crohn's disease in Poland: Retrospective, multicenter studies.
    Iwańczak BM; Ryżko J; Jankowski P; Sładek M; Wasilewska A; Szczepanik M; Sienkiewicz E; Szaflarska-Popławska A; Więcek S; Czaja-Bulsa G; Korczowski B; Maślana J; Iwańczak F; Kacperska M
    Adv Clin Exp Med; 2017; 26(1):51-56. PubMed ID: 28397432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab reduces the number of activated mucosal lymphocytes in patients with Crohn's disease.
    Ferkolj I; Ihan A; Markovic S; Veceric Z; Pohar M
    J Gastrointestin Liver Dis; 2006 Sep; 15(3):231-5. PubMed ID: 17013447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.